Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2003
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055275 Prevention of neutrophil recruitment
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055250 Pteridine compounds for the treatment of psoriasis
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055098 Method of treatment
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055091 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
03/20/2003US20030055080 Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
03/20/2003US20030055073 Remedies for sjoegren's syndrome
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055061 Therapy of disease or condition which is caused by a disorder of the serotonin system by administering 2,7-substituted octahydro-1H-pyrido(1,2-a)pyrazine derivatives, and their acid addition salts
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055045 Novel compounds with analgesic effect
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055037 Benzimidazole and indole derivatives as CRF receptor modulators
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030055028 Administering two separate dosage forms of a topically active corticosteroid or a pharmaceutically active salt thereof for therapy ofinflammatory bowel disease and sufficient to reduce or eliminate side effects
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030054034 Water soluble film forming polymer and microbiocide oil
03/20/2003US20030054014 Administering fungi spores; aging resistance
03/20/2003US20030054011 Anticancer agents
03/20/2003US20030053986 Method of treating hepatitis C infection
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003CA2460330A1 Method for the preparation of crystalline tetrahydrobenzothiepines
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459464A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003CA2459445A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003CA2459310A1 Method and composition for treating immune complex associated disorders
03/20/2003CA2458029A1 Methods of treating cytokine mediated diseases
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/19/2003EP1293567A1 Ligand to gpr8 and dna thereof
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293511A1 Canine liver cell growth factor
03/19/2003EP1293507A1 Process for producing crystal
03/19/2003EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/19/2003EP1292684A2 Proteases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1292608A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
03/19/2003EP1292605A2 Antisense modulation of inhibitor of dna binding-1 expression
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292603A2 Methods and compositions for treating hepatitis c virus
03/19/2003EP1292596A1 1,3,8-triaza-spiro[4,5]decan-4-one derivatives as neurokinin receptor antagonists
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292563A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
03/19/2003EP1292325A1 Matrix protein compositions for dentin regeneration
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292310A1 Novel anti-infectives
03/19/2003EP1292309A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
03/19/2003EP1292296A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
03/19/2003EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes
03/19/2003EP1292282A2 Improved injectable dispersions of propofol
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1137671B1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0944636B1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS
03/19/2003EP0839157B1 Colostrum derived growth factor
03/19/2003EP0833644B1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
03/19/2003EP0758245B1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404388A Multi-step drug dosage forms
03/19/2003CN1404385A Method of using a beverage composition for treating dental erosion
03/19/2003CN1404364A Water containing soluble fiber
03/19/2003CN1403466A Syringic general saponin extractive and its prepn and medicinal composition
03/19/2003CN1403150A Medical health oral liquid and its prepn
03/19/2003CN1403147A Medicines composition for raising body's immunity and its prepn
03/19/2003CN1403143A Composite Chinese medicine for treating gastrointestinal diseases
1 ... 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 ... 1258